- Microsoft Ordered to Stop Some Windows Sales in China
- Former Merrill CEO Thain Defends Wall Street Bonuses
- Obama to Continue Yuan Rhetoric, Visit Great Wall
- Blog: Investing in Green? Don't Buy the Hype
- Boats Seized in Madoff Scandal Sell for $2 Million
- House Leaders Want Job Creation Bill Before Year-End
- Economy, Stocks to Grow Faster Than Many Think: ING
- 15 Richest Members of Congress
- Fed's Exit Strategy: How It May Raise Borrowing Costs
- Best Sector Plays for 2010: Citi's Levkovich
- Pulse of Private Equity
- Abbott, Arbiter & Avoidance
- Can YouTube Revolutionize Citizen Journalism?
- I Have to Leggo My Eggo
- Appraisals Now Center Stage in Housing Recovery
- Expect Stocks to Rise 15-20% by Mid-2010: Chief Investor
- Profiting from This Volatile Options Expiration Week: Analyst
- Nov. 17: Unusual Volume Leaders
- Urban League and partner to offer small biz loans
- Experian credit agency 1H profit down 4.5 percent
- SPIN METER: Feds buy green cars, auction rejects
- Kudzu-munching bug also threatens US bean crops
- Tajiks write off $550 million debt owed by farmers
- Supermarket operator Ahold 3Q profit up 22 percent
- Delta offers $1 billion to Japan Airlines
- Intrawest selling Colo.'s Copper Mountain to Powdr
- China facing energy shortages amid cold spell
By Jessica Wohl
CHICAGO (Reuters) - CVS Caremark Corp <CVS.N> posted a bigger-than-expected jump in quarterly profit on Thursday as consumers filled more prescriptions and said this year's profit should come in towards the higher end of its forecast.
Shares of CVS rose 1 percent in premarket trading.
CVS has benefited from its "Maintenance Choice" program, which allows customers to pick up 90-day prescriptions in its drugstores at the same lower price they would pay if getting the drugs through its pharmacy benefits unit's mail service.
That plan boosted pharmacy sales at stores open at least a year by about 2.5 percentage points in the quarter. Still, same-store sales of general merchandise rose just 0.8 percent, and overall same-store sales fell short of CVS's target.
Profit got a boost as the company dispensed more generic drugs at its stores and through the pharmacy services unit. While generic drugs carry lower revenue, they are typically more profitable than branded products.
CVS earned $1.02 billion, or 71 cents per share, up from $732.5 million, or 50 cents per share, a year earlier.
Adjusted third-quarter earnings from continuing operations were 65 cents per share, while analysts' average forecast was 64 cents, according to Thomson Reuters I/B/E/S.
CVS said it now expects 2009 adjusted earnings per share from continuing operations of $2.61 to $2.64, versus a prior forecast of $2.59 to $2.64. Analysts expect $2.62.
Net revenue in the third quarter jumped 18.1 percent to $24.64 billion, topping analysts' average forecast of $24.61 billion. CVS also got a boost from an extra reporting day in this year's quarter.
Revenue climbed 23.4 percent in the pharmacy services unit and 17.9 percent in the retail unit.
Same-store sales rose 5.7 percent. In August, CVS had forecast an increase of 6 percent to 8 percent.
On Tuesday, rival Walgreen Co <WAG.N> said its same-store sales rose 4.9 percent in October, aided by flu vaccinations.
Walgreen administered 5 million seasonal flu shots this year, up from 1.2 million in 2008. CVS cut its flu shot clinics short last month due to delays in getting vaccines.
(Reporting by Jessica Wohl, editing by Maureen Bavdek, Dave Zimmerman)
- How to put some green into your portfolio.
- Returning from a Ron Paul political rally, one supporter was held at an airport due to the amount of cash he was carrying. NYT reports.
- Chances for a climate change treaty look dim at the Copenhagen conference.
- Dollar rebound? Wait at least another 10 months, charts say.
- Online social networking phenomenon Facebook is the source of New Oxford American Dictionary’s word of the year.
- Hard times in Hollywood are boosting job applications in the porn business.









